A detailed history of Commonwealth Equity Services, LLC transactions in Repligen Corp stock. As of the latest transaction made, Commonwealth Equity Services, LLC holds 6,320 shares of RGEN stock, worth $788,293. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,320
Previous 6,539 3.35%
Holding current value
$788,293
Previous $824,000 14.2%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$119.79 - $167.35 $26,234 - $36,649
-219 Reduced 3.35%
6,320 $941,000
Q2 2024

Jul 31, 2024

SELL
$120.0 - $182.95 $38,520 - $58,726
-321 Reduced 4.68%
6,539 $824,000
Q1 2024

Apr 29, 2024

SELL
$170.78 - $208.42 $60,114 - $73,363
-352 Reduced 4.88%
6,860 $1.26 Million
Q4 2023

Feb 06, 2024

SELL
$114.17 - $185.35 $128,669 - $208,889
-1,127 Reduced 13.51%
7,212 $1.3 Million
Q3 2023

Oct 23, 2023

SELL
$138.78 - $176.51 $8,881 - $11,296
-64 Reduced 0.76%
8,339 $1.33 Million
Q2 2023

Aug 10, 2023

SELL
$138.42 - $180.31 $28,237 - $36,783
-204 Reduced 2.37%
8,403 $1.19 Million
Q1 2023

May 11, 2023

SELL
$154.26 - $198.1 $7,404 - $9,508
-48 Reduced 0.55%
8,607 $1.45 Million
Q4 2022

Feb 07, 2023

SELL
$162.42 - $220.56 $12,993 - $17,644
-80 Reduced 0.92%
8,655 $1.47 Million
Q3 2022

Nov 14, 2022

BUY
$160.42 - $256.21 $3,208 - $5,124
20 Added 0.23%
8,735 $1.63 Million
Q2 2022

Jul 19, 2022

SELL
$140.68 - $188.02 $15,756 - $21,058
-112 Reduced 1.27%
8,715 $1.42 Million
Q1 2022

May 04, 2022

SELL
$161.19 - $257.96 $425,219 - $680,498
-2,638 Reduced 23.01%
8,827 $1.66 Million
Q4 2021

Jan 31, 2022

SELL
$247.59 - $304.47 $179,997 - $221,349
-727 Reduced 5.96%
11,465 $3.04 Million
Q3 2021

Oct 29, 2021

BUY
$194.77 - $324.21 $82,777 - $137,789
425 Added 3.61%
12,192 $3.52 Million
Q2 2021

Aug 11, 2021

SELL
$165.87 - $220.95 $425,456 - $566,736
-2,565 Reduced 17.9%
11,767 $2.35 Million
Q1 2021

May 04, 2021

BUY
$180.37 - $226.26 $495,837 - $621,988
2,749 Added 23.73%
14,332 $2.79 Million
Q4 2020

Feb 11, 2021

BUY
$148.08 - $206.57 $155,632 - $217,105
1,051 Added 9.98%
11,583 $2.22 Million
Q3 2020

Nov 05, 2020

BUY
$122.51 - $158.27 $27,197 - $35,135
222 Added 2.15%
10,532 $1.55 Million
Q2 2020

Aug 12, 2020

BUY
$94.33 - $140.48 $972,542 - $1.45 Million
10,310 New
10,310 $1.27 Million

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $6.92B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Commonwealth Equity Services, LLC Portfolio

Follow Commonwealth Equity Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commonwealth Equity Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Commonwealth Equity Services, LLC with notifications on news.